Scarica l'app Stockscreener
5.78
4.30%
-0.26
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AURA Giù?
Forum
Previsione
Precedente Chiudi:
$6.04
Aprire:
$5.95
Volume 24 ore:
108.42K
Relative Volume:
0.46
Capitalizzazione di mercato:
$359.98M
Reddito:
-
Utile/perdita netta:
$-76.41M
Rapporto P/E:
-3.0104
EPS:
-1.92
Flusso di cassa netto:
$-64.56M
1 W Prestazione:
-9.26%
1M Prestazione:
-4.46%
6M Prestazione:
-6.02%
1 anno Prestazione:
-43.17%
Intervallo 1D:
$5.72
$5.96
Intervallo di 1 settimana:
$5.72
$6.47
Portata 52W:
$4.345
$11.29
Aura Biosciences Inc Stock (AURA) Company Profile
Nome
Aura Biosciences Inc
Settore
Industria
Telefono
(617)500-8864
Indirizzo
80 GUEST STREET, BOSTON
Confronta AURA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AURA
Aura Biosciences Inc
|
5.795 | 375.20M | 0 | -76.41M | -64.56M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
428.46 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
630.92 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
426.02 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
840.84 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.62 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Aura Biosciences Inc Stock (AURA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-28 | Ripresa | H.C. Wainwright | Buy |
| 2024-07-25 | Iniziato | H.C. Wainwright | Buy |
| 2023-07-27 | Iniziato | Scotiabank | Sector Outperform |
| 2023-04-17 | Ripresa | BTIG Research | Buy |
| 2022-07-19 | Iniziato | JMP Securities | Mkt Outperform |
Aura Biosciences Inc Borsa (AURA) Ultime notizie
Published on: 2025-11-04 00:27:04 - newser.com
How analysts rate Aura Biosciences Inc. stock todayQuarterly Earnings Summary & Reliable Momentum Entry Alerts - newser.com
How to build a dashboard for Aura Biosciences Inc. stockJuly 2025 Earnings & Capital Efficiency Focused Ideas - newser.com
Volume spikes in Aura Biosciences Inc. stock – what they mean2025 Technical Patterns & Long-Term Growth Portfolio Plans - newser.com
What drives Aura Biosciences Inc stock priceGap Up/Gap Down Analysis & Get Free Training on Technical Indicators - earlytimes.in
Is it time to cut losses on Aura Biosciences Inc.Oil Prices & Smart Swing Trading Alerts - newser.com
Is Aura Biosciences Inc. stock cheap compared to fundamentalsWeekly Investment Recap & Weekly Breakout Stock Alerts - newser.com
Real time pattern detection on Aura Biosciences Inc. stockTrade Risk Report & AI Enhanced Trade Execution Alerts - newser.com
How Aura Biosciences Inc. stock performs after earningsMarket Risk Report & Daily Growth Stock Tips - newser.com
Can you recover from losses in Aura Biosciences Inc.July 2025 Spike Watch & Safe Entry Point Identification - newser.com
Applying big data sentiment scoring on Aura Biosciences Inc.Market Risk Report & Reliable Entry Point Trade Alerts - newser.com
How Aura Biosciences Inc. stock performs in weak economyWeekly Trade Recap & Fast Gain Swing Alerts - newser.com
Should you hold or exit Aura Biosciences Inc. nowJuly 2025 Trends & Low Risk Growth Stock Ideas - newser.com
Aura Biosciences Inc. stock outlook for YEAR2025 Performance Recap & Fast Momentum Entry Tips - newser.com
Aura Biosciences CEO Makes Significant Stock Sale! - TipRanks
Aura Biosciences Director Elisabet de los Pinos Sells Shares to Cover Tax Obligations - TradingView
Form 4: AURA officer automatic sale of 896 shares to cover taxes - Stock Titan
AURA insider sale: 9,049 shares at $6.35 for RSU withholding - Stock Titan
Aura Biosciences’ Phase 3 Trial: A Potential Game-Changer in Ocular Melanoma Treatment - TipRanks
Aura Biosciences, Inc. (NASDAQ:AURA) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Is Aura Biosciences Inc. stock trading near support levelsEarnings Trend Report & Safe Swing Trade Setups - Fundação Cultural do Pará
Aura Biosciences Advances Bladder Cancer Treatment with AU-011 Study - TipRanks
Aura Biosciences Advances Eye Cancer Treatment with Phase 2 Trial Update - TipRanks
Published on: 2025-10-27 06:14:42 - newser.com
Aura Biosciences Inc Azioni (AURA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.41%
0.58%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):